Highlights
LSE: OXB       OXFORD BIOMEDICA PLC ORD 1P
Last Price Today's Change   Day's Range   Trading Volume
1,332.00   -18.00 (1.33%)  1,298.00 - 1,360.00  76,818

Overview

 
Avg Volume (4 weeks):86,659
4 Weeks Range:1,262.00 - 1,400.00
4 Weeks Price Volatility (%):
50.72%
52 Weeks Range:745.00 - 1,400.00
52 Weeks Price Volatility (%):
89.62%
Average Price Target: 6.90
Price Target Upside/Downside: -1,325.10

Headlines



No recent Headlines for this stock.


Business Background

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D segment is engaged in the development of in-vivo and ex-vivo gene and cell therapy products, and the development of lentivirus-related platform technology. The Company provides a platform of technologies and capabilities with which it designs, develops and produces gene and cell-based medicines. The Company's product pipeline of OXB-102, OXB-201, OXB-202 and OXB-302 addresses neurodegenerative and ocular diseases, and a range of cancers. OXB-102 is indicated for Parkinson's disease. OXB-202 is indicated for Ocular (corneal graft rejection). OXB-302 is indicated for cancer disease. Its OXB-201 is indicated for wet age-related macular degeneration.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1856  1399  655  1071 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AEG 0.525+0.075 
 LLOY 45.635-0.565 
 KOD 0.38-0.015 
 PREM 0.183-0.01 
 UKOG 0.1630.00 
 TRP 0.47+0.09 
 88E 2.10+0.10 
 INSP 0.05+0.002 
 GBP 0.485+0.05 
 VELA 0.0730.00